Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies. [electronic resource]
- Journal of molecular medicine (Berlin, Germany) Jul 2014
- 709-22 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1432-1440
10.1007/s00109-014-1161-2 doi
Animals Antibodies, Monoclonal--therapeutic use Antineoplastic Agents--therapeutic use Biomarkers, Tumor--metabolism Colorectal Neoplasms--drug therapy Drug Resistance, Neoplasm Humans Protein-Tyrosine Kinases--antagonists & inhibitors